Clinical effect of laparoscopic splenectomy and pericardial devascularization in portal hypertension patients with Child-Pugh A/B liver function

Changxu LI; Luyao XU; Na RU; Xuekang REN; Chaohui TANG; Yingchao WANG

doi:10.3969/j.issn.1001-5256.2021.03.018

Volume 37 Issue 3

Mar. 2021

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(3): 596-600

PDF( 1806 KB)

Clinical effect of laparoscopic splenectomy and pericardial devascularization in portal hypertension patients with Child-Pugh A/B liver function

DOI: 10.3969/j.issn.1001-5256.2021.03.018

Second Department of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University, Changchun 130000, China

Received Date: 2020-09-06
Accepted Date: 2020-09-22
Published Date: 2021-03-20

Abstract

Abstract

Objective To investigate the clinical effect of laparoscopic splenectomy and pericardial devascularization (LSPD) in patients with portal hypertension and the long-term effect of LSPD. Methods A total of 40 portal hypertension patients with Child-Pugh A/B liver function who received LSPD in The First Hospital of Jilin University from August to December 2017 were enrolled as surgical group, and 44 portal hypertension patients with Child-Pugh A/B liver function who received conservative treatment during the same period of time was enrolled as internal medicine group. The patients were followed up to June 30, 2019, and liver function parameters, upper gastrointestinal bleeding, and portal vein thrombosis were recorded for all patients at each time point. The t-test was used for comparison of normally distributed continuous data between two groups; an analysis of variance was used for comparison between multiple groups, and the Bonferroni test was used for further comparison between two groups. The Kruskal-Wallis H test was used for comparison of continuous data with skewed distribution; between multiple groups, and the Mann-Whitney U test was used for further comparison between two groups. The chi-square test was used for comparison of categorical data between groups. Results At 6, 12, and 24 months after discharge, compared with the internal medicine group, the surgical group had a significantly higher level of cholinesterase (t=3.527, 3.849, and 5.555, all P < 0.05) and a significantly lower Child-Pugh score (t=2.498, 2.138, and 2.081, all P < 0.05). Compared with the internal medicine group at 12 and 24 months after discharge, the surgical group had a significantly higher level of albumin (t=3.120 and 2.587, both P < 0.05) and a significantly lower incidence rate of upper gastrointestinal bleeding (χ²=4.947 and 5.155, both P < 0.05). At 24 months after discharge, the surgical group had a significantly lower number of patients who had a significant increase in alpha-fetoprotein level than the internal medicine group (χ²=4.648, P=0.031). At 12 months after discharge, the surgical group had a significantly higher incidence rate of portal vein thrombosis than the internal medicine group (χ²=4.395, P=0.036). The surgical group had significant improvements in albumin (F=2.959, P=0.013), cholinesterase (F=11.022, P < 0.001), prothrombin time (H=94.100, P < 0.001), and Child-Pugh score (F=3.742, P=0.003) from admission to 12 and 24 months after surgery. Conclusion In portal hypertension patients with Child-Pugh A/B liver function, LSPD can improve liver function and reduce the incidence rate of upper gastrointestinal bleeding, and the high incidence rate of portal vein thrombosis can be effectively reduced by oral aspirin and rivaroxaban.
- Liver Cirrhosis,
- Hypertension, Portal,
- Laparoscopic Splenectomy And Pericardial Devascularization

FullText(HTML)

References(24)

References

[1]	HERRERA JL. Portal hypertension[J]. Clin Liver Dis, 2014, 18(2): xiii-xiv. DOI: 10.1016/j.cld.2014.02.001
[2]	BALDUCCI G, STERPETTI AV, VENTURA M. A short history of portal hypertension and of its management[J]. J Gastroenterol Hepatol, 2016, 31(3): 541-545. DOI: 10.1111/jgh.13200
[3]	ZHAO H, ZHAO R, HU J, et al. Upper gastrointestinal hemorrhage in acute-on-chronic liver failure: Prevalence, characteristics, and impact on prognosis[J]. Expert Rev Gastroenterol Hepatol, 2019, 13(3): 263-269. DOI: 10.1080/17474124.2019.1567329
[4]	HONG DF. Concept and technical innovation of laparoscopic splenectomy combined with peripheral cardia vascular interruption[J/CD]. Chin J Laparoscopic Surgery (Electronic Edition), 2018, 11(2): 68-71. (in Chinese) 洪德飞. 腹腔镜脾切除联合贲门周围血管离断术理念与技术创新[J/CD]. 中华腔镜外科杂志(电子版), 2018, 11(2): 68-71.
[5]	ZHANG HW, WANG ML, ZHANG Z, et al. The impact of splenectomy and devascularization on liver function and liver fibrosis in patients with non-cirrhotic portal hypertension[J]. Chin J Hepatobiliary Surg, 2019, 25(7): 501-504. (in Chinese) http://d.wanfangdata.com.cn/periodical/sdyy202021015 张宏伟, 王孟龙, 张振, 等. 脾切除联合贲门周围血管离断术对非硬化性门静脉高压患者肝功能及肝纤维化的影响[J]. 中华肝胆外科杂志, 2019, 25(7): 501-504 http://d.wanfangdata.com.cn/periodical/sdyy202021015
[6]	ZHANG Y, WEN TF, CHEN ZY, et al. Liver functions after periesophagogastric devascularization[J]. Chin J Gen Surg, 2009, 24(6): 470-472. (in Chinese) DOI: 10.3760/cma.j.issn.1007-631X.2009.06.014 张宇, 文天夫, 陈哲宇, 等. 脾切除贲门周围血管离断术后肝脏血流动力学和储备功能的变化[J]. 中华普通外科杂志, 2009, 24(6): 470-472. DOI: 10.3760/cma.j.issn.1007-631X.2009.06.014
[7]	HUA R, WU ZY, SUN YW, et al. A study on the relationship between post-devascularization portal pressure and rebleeding in portal hypertensive patients[J]. Chin J Gen Surg, 2007, 22(3): 194-196. (in Chinese) DOI: 10.3760/j.issn:1007-631X.2007.03.010 花荣, 吴志勇, 孙勇伟, 等. 断流术中门静脉压力变化及术后再出血的临床研究[J]. 中华普通外科杂志, 2007, 22(3): 194-196. DOI: 10.3760/j.issn:1007-631X.2007.03.010
[8]	JIANG FD, TIAN MG, YANG Y, et al. Changing rules of free portal pressure and influencing factors after splenectomy combined with pericardial devascularization[J]. Chin J Dig Surg, 2019, 18(4): 375-379. (in Chinese) DOI: 10.3760/cma.j.issn.1673-9752.2019.04.013 蒋福东, 田明国, 杨勇, 等. 脾切除联合贲门周围血管离断术后自由门静脉压力变化规律及其影响因素分析[J]. 中华消化外科杂志, 2019, 18(4): 375-379. DOI: 10.3760/cma.j.issn.1673-9752.2019.04.013
[9]	ZHANG CY, LIU ZJ. Surgical treatment of cirrhotic portal hypertension: Current status and research advances[J]. J Clin Hepatol, 2020, 36(2): 417-420. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.02.040 张春雨, 刘作金. 肝硬化门静脉高压外科治疗的现状及进展[J]. 临床肝胆病杂志, 2020, 36(2): 417-420. DOI: 10.3969/j.issn.1001-5256.2020.02.040
[10]	JIANG GQ, BAI DS, QIAN JJ, et al. Clinical efficacy of laparoscopic splenectomy combined with pericardial devascularization in the treatment of cirrhotic portal hypertension: A report of 445 cases[J]. Chin J Dig Surg, 2019, 18(12): 1136-1141. (in Chinese) DOI: 10.3760/cma.j.issn.1673-9752.2019.12.009 蒋国庆, 柏斗胜, 钱建军, 等. 腹腔镜脾切除联合贲门周围血管离断术治疗肝硬化门静脉高压症临床疗效分析(附425例报告)[J]. 中华消化外科杂志, 2019, 18(12): 1136-1141. DOI: 10.3760/cma.j.issn.1673-9752.2019.12.009
[11]	XU DW, SUN M, WU M, et al. Totally laparoscopic splenectomy plus pericardial devascularization in treatment of portal hypertension: Importance of surgical teamwork and technical hints[J]. Chin J Hepatobiliary Surg, 2019, 25(8): 611-615. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201405021.htm 许丁伟, 孙敏, 吴敏, 等. 腹腔镜脾切除联合贲门周围血管离断术治疗门静脉高压症的团队协作与技巧[J]. 中华肝胆外科杂志, 2019, 25(8): 611-615. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201405021.htm
[12]	BAI DS, ZHOU BH, QIAN JJ, et al. Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: A 2-year prospective study[J]. Surg Endosc, 2020, 34(11): 5074-5082. DOI: 10.1007/s00464-019-07307-7
[13]	KOK B, ABRALDES JG. Child-Pugh classification: Time to abandon?[J]. Semin Liver Dis, 2019, 39(1): 96-103. DOI: 10.1055/s-0038-1676805
[14]	CHRISTENSEN E, SCHLICHTING P, FAUERHOLDT L, et al. Changes of laboratory variables with time in cirrhosis: Prognostic and therapeutic significance[J]. Hepatology, 1985, 5(5): 843-853. DOI: 10.1002/hep.1840050523
[15]	PAK JM, LEE SS. Glucagon in portal hypertension[J]. J Hepatol, 1994, 20(6): 825-832. DOI: 10.1016/S0168-8278(05)80156-4
[16]	LANGER DA, SHAH VH. Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis[J]. J Hepatol, 2006, 44(1): 209-216. DOI: 10.1016/j.jhep.2005.10.004
[17]	HSIN IF, HUANG HC, CHANG CC, et al. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes[J]. Clin Sci (Lond), 2018, 132(22): 2391-2405. DOI: 10.1042/CS20180557
[18]	MCKENZIE CV, COLONNE CK, YEO JH, et al. Splenomegaly: Pathophysiological bases and therapeutic options[J]. Int J Biochem Cell Biol, 2018, 94: 40-43. DOI: 10.1016/j.biocel.2017.11.011
[19]	RIVA MA, FERRAINA F, PALEARI A, et al. From sadness to stiffness: The spleen's progress[J]. Intern Emerg Med, 2019, 14(5): 739-743. DOI: 10.1007/s11739-019-02115-2
[20]	LEWIS SM, WILLIAMS A, EISENBARTH SC. Structure and function of the immune system in the spleen[J]. Sci Immunol, 2019, 4(33): eaau6085. DOI: 10.1126/sciimmunol.aau6085
[21]	ZHAO YP, JIANG HC, YANG LY, et al. General surgery[M]. 2nd ed. Beijing: People's Medical Publishing House, 2014. (in Chinese) 赵玉沛, 姜洪池, 杨连粤, 等. 普通外科学[M]. 2版. 北京: 人民卫生出版社, 2014.
[22]	UEDA S, YAMANOI A, HISHIKAWA Y, et al. Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats[J]. Lab Invest, 2003, 83(11): 1595-1603. DOI: 10.1097/01.LAB.0000095686.10639.C8
[23]	LESURTEL M, GRAF R, ALEIL B, et al. Platelet-derived serotonin mediates liver regeneration[J]. Science, 2006, 312(5770): 104-107. DOI: 10.1126/science.1123842
[24]	CHEN XP, YANG LY, QIU GX, et al. Surgery(Volume 2)[M]. 2nd ed. Beijing: People's Medical Publishing House, 2010. (in Chinese) 陈孝平, 杨连粤, 邱贵兴, 等. 外科学(下册)[M]. 2版. 北京: 人民卫生出版社, 2010.

Relative Articles

[1]	Mingqiang ZHU, Dashuai YANG, Xiangyun XIONG, Junpeng PEI, Yang PENG, Youming DING. Establishment and validation of a nomogram risk prediction model for infection complications in patients after hepatectomy for liver cancer[J]. Journal of Clinical Hepatology, 2023, 39(1): 110-117. doi: 10.3969/j.issn.1001-5256.2023.01.017
[2]	Haoyou TANG, Sheng LIU, Xin ZENG, Xiaobin HUANG, Yang YANG, Dawei DENG, Jianshui LI. Establishment of a nomogram for survival rate after liver resection for primary small hepatocellular carcinoma based on SEER data and external validation[J]. Journal of Clinical Hepatology, 2022, 38(1): 110-116. doi: 10.3969/j.issn.1001-5256.2022.01.017
[3]	Jun LING, Wenwu WAN, Zheng ZENG, Huihua YAO, Ou JIANG, Bing DING. Clinical effect of transcatheter arterial chemoembolization combined with microwave ablation versus repeat resection in treatment of recurrent hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(9): 2053-2060. doi: 10.3969/j.issn.1001-5256.2022.09.020
[4]	Ying LIU, Benjian GAO, Xiaoli YANG, Cheng FANG, Song SU, Bo LI. Effect of hemihepatic vascular exclusion versus total hepatic vascular exclusion in hepatectomy for primary liver cancer: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(1): 73-78. doi: 10.3969/j.issn.1001-5256.2021.01.015
[5]	Di ZHAO, Jindong YE, Huali LI, Kui JIN, Xiang LIU, Xiaoran LI, Liuxin DUAN, Jungui LIU, Wei LYU, Weihong DUAN, Quanda LIU. Application of liver three-dimensional visualized reconstruction technique in hepatectomy for children with complicated hepatoblastoma[J]. Journal of Clinical Hepatology, 2021, 37(9): 2130-2135. doi: 10.3969/j.issn.1001-5256.2021.09.025
[6]	Minjun LI, Zhujian DENG, Haotian LIU, Yuxian TENG, Rongrui HUO, Xiumei LIANG, Bangde XIANG, Lequn LI, Jianhong ZHONG. Clinical effect of re-hepatic resection versus radiofrequency ablation in treatment of recurrent hepatocellular carcinoma in Asia: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(5): 1103-1109. doi: 10.3969/j.issn.1001-5256.2021.05.025
[7]	Mingwei LI, Jian GAO, Xiangwei ZHAI, Xiangjun QIAN, Xiajie WEN, Mingjie YAO, Zhaojun DUAN, Erjiang ZHAO, Ling ZHANG, Fengmin LU. Construction and analysis of a predictive model for posthepatectomy recurrence in patients with hepatocellular carcinoma based on preoperative CXCL13 measurement[J]. Journal of Clinical Hepatology, 2021, 37(4): 823-828. doi: 10.3969/j.issn.1001-5256.2021.04.020
[8]	Bohui LIN, Yimeng OU. Application of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(1): 180-183. doi: 10.3969/j.issn.1001-5256.2021.01.039
[9]	Chunxia PING, Jing ZHANG, Wei ZHAO, Liang MA, Da FANG, Shichang CUI. Three-year follow-up outcomes of hepatocellular carcinoma patients undergoing liver resection versus liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(2): 343-347. doi: 10.3969/j.issn.1001-5256.2021.02.019
[10]	Gao BenJian, Luo Jia, Liu Ying, Yang XiaoLi, Su Song, Li Bo. Efficacy and safety of laparoscopic versus open liver resection in treatment of colorectal cancer liver metastasis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(3): 573-579. doi: 10.3969/j.issn.1001-5256.2020.03.021
[11]	Wang XueWen, Li Han, Wu YanBin, Niu HongKai, Kong LingQun, Cheng Yu. Hepatectomy as the preferred approach for radical resection of Bismuth Ⅳ hilar cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2020, 36(9): 2059-2062. doi: 10.3969/j.issn.1001-5256.2020.09.030
[12]	Liao Yang, Li ShengWei. Current status of associating liver partition and portal vein ligation for staged hepatectomy in treatment of liver metastasis of colorectal cancer[J]. Journal of Clinical Hepatology, 2019, 35(12): 2805-2808. doi: 10.3969/j.issn.1001-5256.2019.12.035
[13]	Wang XinWei, Wang WeiNa, Zhang ZongLi. Surgical outcome and survival of patients with spontaneous rupture and bleeding of hepatocellular carcinoma after hepatectomy[J]. Journal of Clinical Hepatology, 2019, 35(1): 114-118. doi: 10.3969/j.issn.1001-5256.2019.01.021
[14]	Tian Zhou, Zhang JianHuai, Sun XiTai, Liu Bin, Qi FuZhen, Wang YeBo, Wu JinSheng, Gu DianHua. Experience in laparoscopic hepatectomy in treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(8): 1712-1716. doi: 10.3969/j.issn.1001-5256.2018.08.024
[15]	Li Xin. Short-and long-term efficacy of transarterial chemoembolization versus liver resection in treatment of patients with Barcelona stage B multiple hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(7): 1296-1300. doi: 10.3969/j.issn.1001-5256.2017.07.018
[16]	Xiong Yong, Wang HeBin, Liu DeQin, Chen JianXun, Liu JianPing, Sun ChangQin. Total laparoscopic hepatectomy versus open hepatectomy in treatment of hepatocellular carcinoma in the left lateral lobe: a case- matched analysis[J]. Journal of Clinical Hepatology, 2016, 32(4): 735-738. doi: 10.3969/j.issn.1001-5256.2016.04.026
[17]	Ma YiYun, Jiang Hua, Zhang HongHeng. Clinical effect of laparoscopic versus open liver resection in treatment of patients with hepatocellular carcinoma complicated by liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(10): 1916-1919. doi: 10.3969/j.issn.1001-5256.2016.10.018
[18]	Shen YiNan, Huang ShengYu, Hu XianRong, Wang Jie, Yu HongMing, Lu Wen, Lu JunHua, Yang GuangShun, Wu MengChao. Clinical effect of laparoscopic hepatectomy in treating liver metastasis of colon cancer: a systematic review and meta-analysis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1287-1291. doi: 10.3969/j.issn.1001-5256.2014.12.013
[19]	Chen Kai, Qiu FuNan, Tian YiFeng, Lai ZhiDe, Zhou SongQiang, Yan MaoLin, Wang YaoDong. Application of hepatectomy without hepatic blood flow occlusion in treatment of primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(10): 1060-1063. doi: 10.3969/j.issn.1001-5256.2014.10.021
[20]	Xu JunHui, Ding YouMing, Wang Bin, Fang HanGang. Clinical value of laparoscopic hepatectomy in liver cancer patients with cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(6): 552-555. doi: 10.3969/j.issn.1001-5256.2014.06.019

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(4)

Get Citation

PDF

XML

Article Metrics

Article views (567) PDF downloads(39)

Clinical effect of laparoscopic splenectomy and pericardial devascularization in portal hypertension patients with Child-Pugh A/B liver function

DOI: 10.3969/j.issn.1001-5256.2021.03.018

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Clinical effect of laparoscopic splenectomy and pericardial devascularization in portal hypertension patients with Child-Pugh A/B liver function

DOI: 10.3969/j.issn.1001-5256.2021.03.018

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content